References
- World Health Organization [webpage on the Internet]Burden of COPDGenevaWorld Health Organization2017 Available from: http://www.who.int/respiratory/copd/burden/en/Accessed January 23, 2017
- LopezADShibuyaKRaoCChronic obstructive pulmonary disease: current burden and future projectionsEur Respir J200627239741216452599
- Australian Institute of Health and Welfare [webpage on the Internet]Australia’s Health 20162016 Available from: http://www.aihw.gov.au/copd/Accessed February 23, 2017
- HillKGoldsteinRSGuyattGHPrevalence and under-diagnosis of chronic obstructive pulmonary disease among patients at risk in primary careCMAJ2010182767367820371646
- BednarekMMaciejewskiJWozniakMKucaPZielinskiJPrevalence, severity and under-diagnosis of COPD in the primary care settingThorax200863540240718234906
- VandevoordeJVerbanckSGijsselsLEarly detection of COPD: a case finding study in general practiceRespir Med2007101352553016908127
- JordanRELamKBChengKKCase finding for chronic obstructive pulmonary disease: a model for optimising a targeted approachThorax201065649249820522845
- XuanWToelleBGBirdTPrevalence of respiratory symptoms, illnesses and spirometric diagnoses by age group and sex: the burden of lung disease (BOLD) studyA50. COPD EpidemiologyAmerican Thoracic Society2011183A1734Denver, Colorado
- LindbergABjerg-BacklundARonmarkELarssonLGLundbackBPrevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking report from the obstructive lung disease in Northern Sweden StudiesRespir Med2006100226427215975774
- Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2017 Available from: www.goldcopd.orgAccessed March 30, 2017
- AkazawaMHalpernRRiedelAAStanfordRHDalalABlanchetteCMEconomic burden prior to COPD diagnosis: a matched case-control study in the United StatesRespir Med2008102121744175218760581
- VermeirePThe burden of chronic obstructive pulmonary diseaseRespir Med200296suppl CS3S10
- LevyMLQuanjerPHBookerRCooperBGHolmesSSmallIDiagnostic spirometry in primary care: proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendationsPrim Care Respir J200918313014719684995
- FabbriLMBoschettoPMappCECOPD guidelines: the important thing is not to stop questioningAm J Respir Crit Care Med2007176652752817823358
- SorianoJBZielinskiJPriceDScreening for and early detection of chronic obstructive pulmonary diseaseLancet2009374969172173219716965
- HanMKKimMGMardonRSpirometry utilization for COPD: how do we measure up?Chest2007132240340917550936
- JooMJLeeTAWeissKBGeographic variation of spirometry use in newly diagnosed COPDChest20081341384518347201
- WiltTJNiewoehnerDKimCUse of Spirometry for Case Finding, Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD). Summary, Evidence Report/Technology Assessment No. 12Rockville, MDAgency for Healthcare Research and Quality Prepared by the Minnesota Evidence-Based Practice Center2005AHRQ Publication No: 05-E017-1 Contract No: 290-02-0009
- FrithPCrockettABeilbyJSimplified COPD screening: validation of the PiKo-6® in primary carePrim Care Respir J201120219019821597667
- Van den BemtLWoutersBCGrootensJDenisJPoelsPJSchermerTRDiagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional studyNPJ Prim Care Respir Med2014241403325119686
- JingJYHuangTCCuiWXuFShenHHShould FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A meta-analysisChest2009135499199819349398
- The Pharmacy Guild of AustraliaServing Australians: A system of community pharmacy2016 Available from: https://www.guild.org.au/__data/assets/pdf_file/0020/5942/serving-australians-a-system-of-community-pharmacy.pdfAccessed August 30, 2017
- YangIADabscheckEGeorgeJThe COPD-X Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2017 Version 2.50, June 2017. Available from: http://copdx.org.au/copd-x-plan/Accessed August 30, 2017
- SichletidisLSpyratosDPapaioannouMA combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care settingPrim Care Respir J201120218418921597666
- CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
- AllanHDiamandisSSainiBMarshallDGavagnaGPeterson-ClarkGA Collaborative Screening, Referral and Management Process to Improve Health Outcomes in Chronic Obstructive Pulmonary Disease (COPD)2017 Available from: http://6cpa.com.au/wp-content/uploads/A-Collaborative-Screening-Referral-and-Management-Process-to-Improve-Health-Outcomes-in-Chronic-Obstructive-Pulmonary-Disease-COPD-Final-Report-Appendices-Part-Final-Report.pdfAccessed August 4, 2017
- Lung FoundationThe Results Record Form for COPD Case Finding – Pharmacy2017 Available from: http://lungfoundation.com.au/wp-content/uploads/2014/02/Results-Form-Pharmacy-20170314.pdfAccessed August 8, 2017
- ToelleBGXuanWBirdTERespiratory symptoms and illness in older Australians: the burden of obstructive lung disease (BOLD) studyMed J Aust2013198314414823418694
- US Preventive Services Task Force (USPSTF)SiuALBibbins-DomingoKScreening for chronic obstructive pulmonary disease US preventive services task force recommendation statementJAMA2016315131372137727046365
- CastilloDBurgosFGuaytaRFARMAEPOC groupAirflow obstruction case finding in community-pharmacies: a novel strategy to reduce COPD underdiagnosisRespir Med2015109447548225754101
- AIHW [webpage on the Internet]Australia’s Health 2016. Australia’s Health No. 15. Cat. No. AUS 199CanberraAIHW2016 Available from: http://www.aihw.gov.au/rural-health/access-to-health-services/Accessed May 14, 2017
- ZwarNBunkerJMReddelHKEarly intervention for chronic obstructive pulmonary disease by practice nurse and GP teams: a cluster randomized trialFam Pract201633666367027535327
- BereznickiBWaltersHWaltersJPetersonGBereznickiLInitial diagnosis and management of chronic obstructive pulmonary disease in Australia: views from the coal faceIntern Med J201747780781310.1111/imj.1341828276136
- QuanjerPHStanojevicSColeTJBaurXHallGLCulverBMulti-ethnic reference values for spirometry for the 3–95 year age range: the global lung function 2012 equationsEur Respir J20124061324134322743675
- WrightDTwiggMThornleyTChronic obstructive pulmonary disease case finding by community pharmacists: a potential cost-effective public health interventionInt J Pharm Pract2015231838525371146
- CastilloDGuaytaRGinerJFARMAEPOC groupCOPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot studyRespir Med2009103683984519200706
- FullerLConradWFHeatonPCPanosREschenbacherWFredeSMPharmacist-managed chronic obstructive pulmonary disease screening in a community settingJ Am Pharm Assoc2012525e59e66